Better Choice to Explore Non-Equity Related Capital Solutions to Fund the R&D of its Domestic Animal Targeted GLP1 Supplement

Rhea-AI Summary

Better Choice Company (BTTR) announces plans to monetize its R&D platform after acquiring Aimia. The company aims to develop a treat-based GLP1 supplement to combat obesity in pets.

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced that after successfully completing the acquisition of Aimia, the Company will explore and evaluate proposals to monetize and fund ownership in its R&D platform with the goal to bring in partners to participate in the evolution of a treat-based GLP1 supplement to combat obesity in dogs and cats.

About Better Choice Company, Inc.
Better Choice Company Inc. is a pet health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier, and longer lives. We offer a broad portfolio of pet health and wellness products for dogs and cats sold under our Halo brand across multiple forms, including foods, treats, toppers, dental products, chews, and supplements. We have a demonstrated, multi-decade track record of success and are well positioned to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. Our products consist of kibble and canned dog and cat food, freeze-dried raw dog food, and treats, vegan dog food and treats, oral care products and supplements. Halo’s core products are made with high-quality, thoughtfully sourced ingredients for natural, science-based nutrition. Each innovative recipe is formulated with leading veterinary and nutrition experts to deliver optimal health. For more information, please visit https://www.betterchoicecompany.com.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com

What did Better Choice Company (BTTR) announce regarding its R&D platform?

Better Choice Company (BTTR) announced plans to explore and evaluate proposals to monetize and fund ownership in its R&D platform.

What is the goal of Better Choice Company (BTTR) in developing a treat-based supplement?

The goal is to combat obesity in dogs and cats by developing a treat-based GLP1 supplement.

Who did Better Choice Company (BTTR) acquire before announcing these plans?

Better Choice Company (BTTR) acquired Aimia before announcing plans to monetize its R&D platform.